BioSpace News Archive

Imara Inc., a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin and other serious diseases, announced that the Company will participate in the following upcoming virtual investor conferences in September:

Ionis Pharmaceuticals, Inc., the leader in RNA-targeted therapies, announced it will present 14 posters and two symposiums highlighting new scientific insights from its ATTR amyloidosis portfolio at the 3rd European ATTR Amyloidosis meeting for Patients and Doctors on September 6-8, 2021.

Zimmer Biomet Holdings, Inc., a global medical technology leader, announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2021.

Concert Pharmaceuticals, Inc. announced that it will participate virtually at the following upcoming investor conferences.

G1 Therapeutics, Inc., a commercial-stage oncology company, announced the grant of inducement stock options exercisable for an aggregate of 43,400 shares of G1’s common stock to eight employees under the G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan.

G1 Therapeutics, Inc., a commercial-stage oncology company, announced that the Company will participate in two upcoming virtual investor conferences in September.

PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company has received Human Research Ethics Committee (HREC) clearance to commence the Phase II combination trial of olinvacimab, PharmAbcine’s anti-VEGFR2 antibody, and KEYTRUDA® (pembrolizumab).

UroGen Pharma Ltd. a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, announced the grants of inducement restricted stock units to 19 new employees in connection with their employment with UroGen.

Centene Corporation announced it will present at the Morgan Stanley 19th Annual Healthcare Conference, to be held September 9-10 and 13-14, 2021.

Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) today announced that members of its senior management team are scheduled to participate in the Morgan Stanley 19th Annual Global Healthcare Conference.